导航
| 股票代码 | 股票名称 | 仓位比例 | 涨跌 | 贡献增长率 |
| 600276 | 恒瑞医药 | 4.87% | -0.66% | -0.0321% |
| 300122 | 智飞生物 | 4.25% | -2.23% | -0.0948% |
| 600129 | 太极集团 | 4.06% | -2.11% | -0.0857% |
| 300558 | 贝达药业 | 3.54% | -0.13% | -0.0046% |
| 300573 | 兴齐眼药 | 3.52% | -0.04% | -0.0014% |
| 688382 | 益方生物 | 3.42% | -0.63% | -0.0215% |
| 300765 | 新诺威 | 3.26% | 2.94% | 0.0958% |
| 688062 | 迈威生物 | 3.16% | 0.76% | 0.0240% |
| 688076 | 诺泰生物 | 3.06% | -2.12% | -0.0649% |
| 300760 | 迈瑞医疗 | 3.03% | 0.31% | 0.0094% |
| 重仓股合计:36.17%, 重仓股贡献增长率: -0.1758%, 总持股仓位:91.66%,修正增长率: | ||||
| 日期 | 实际增长率 | 预估增长率 |
| 2024-04-23 | 0.93% | 0.91% |
| 2024-04-22 | 1.14% | 1.91% |
| 2024-04-19 | -0.07% | -1.03% |
| 2024-04-18 | -0.63% | -1.36% |
| 2024-04-17 | 0.94% | 1.69% |
| 2024-04-16 | -1.72% | -2.06% |
| 2024-04-15 | -0.48% | 0.59% |
| 2024-04-12 | 0.01% | -0.42% |
| 基金名称 | 单位净值 | 增长率 |
| 睿智C | 1.2194 | 1.7034% |
| 游戏传媒 | 0.8029 | 1.6078% |
| 浦银安盛港股通量化混合 | 0.7348 | 1.1679% |
| 浦银医疗 | 1.0375 | 0.9122% |
| 浦银安盛价值精选混合C | 0.7813 | 0.8717% |
| 浦银安盛科创三年封闭混合 | 0.7788 | 0.7991% |
| 浦银生活 | 2.4239 | 0.7605% |
| 浦银安盛ESG责任投资混合A | 0.6895 | 0.7335% |
| 浦银安盛ESG责任投资混合C | 0.6822 | 0.7335% |
| 浦银安盛兴耀优选一年持有混合C | 0.5790 | 0.5052% |
| 基金名称 | 单位净值 | 增长率 |
| 0.7768 | 6.0755% | |
| 嘉实互融精选股票 | 1.1036 | 5.8227% |
| 1.1014 | 5.8227% | |
| 金鹰多元策略混合 | 0.7749 | 5.7248% |
| 金鹰鑫富混合A | 0.9681 | 5.7184% |
| 金鹰鑫富混合C | 0.9994 | 5.7184% |
| 平安核心优势混合A | 1.4472 | 5.3872% |
| 平安核心优势混合C | 1.3818 | 5.3872% |
| 鹏华创新增长一年持有期混合A | 0.9227 | 4.9623% |
| 鹏华创新增长一年持有期混合C | 0.9090 | 4.9623% |
